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Abstract Protective immunity relies upon T cell differ-
entiation and subsequent migration to target tissues.
Similarly, immune homeostasis requires the localization of
regulatory T cells (Tregs) to the sites where immunity takes
place. While naı¨ve T lymphocytes recirculate predomi-
nantly in secondary lymphoid tissue, primed T cells and
activated Tregs must traffic to the antigen rich non-lym-
phoid tissue to exert effector and regulatory responses,
respectively. Following priming in draining lymph nodes,
T cells acquire the ‘homing receptors’ to facilitate their
access to specific tissues and organs. An additional level of
topographic specificity is provided by T cells receptor
recognition of antigen displayed by the endothelium. Fur-
thermore, co-stimulatory signals (such as those induced by
CD28) have been shown not only to regulate T cell acti-
vation and differentiation, but also to orchestrate the
anatomy of the ensuing T cell response. We here review
the molecular mechanisms supporting trafficking of both
effector and regulatory T cells to specific antigen-rich
tissues.
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Introduction: lymphocyte recirculation
and homing
Effective immune surveillance relies on the continuous
trafficking of lymphocytes through blood, lymphoid organs
and non-lymphoid tissue in a process known as recircula-
tion [1]. The physiological process by which lymphocytes
leave circulation, cross endothelium, find and localize to
particular tissues is known as extravasation [2]. In healthy
tissue, the vascular endothelium forms a non-thrombotic,
non-adhesive barrier, and is impermeable to macro-
molecules [3]. Upon inflammation, endothelial cells (ECs)
undergo physiological and molecular changes such as the
up-regulation of adhesion molecule expression. This in turn
allows the exit of lymphocytes across the endothelium into
the tissue without disrupting endothelial integrity.
The initial stage of lymphocyte trafficking is mostly
mediated by selectins, which are responsible for lympho-
cyte transient tethering and rolling on the endothelium [4].
This initial contact between the circulating lymphocytes
and the endothelium monolayer facilitates lymphocyte
exposure to chemokines displayed on the EC surface,
which induces intracellular signalling responses leading to
lymphocyte integrin activation. Activated integrins bind to
their ligands, such as the intercellular adhesion molecule-1
(ICAM-1), vascular cell adhesion molecule-1 (VCAM-1),
and mucosal addressin cell adhesion molecule-1 (MAd-
CAM-1), expressed on the endothelium, resulting in the
firm arrest of lymphocytes on the endothelium [5–7]. Fol-
lowing firm adhesion on the EC monolayer, lymphocytes
eventually transmigrate into the tissue. Lymphocyte
transendothelial migration can occur at the junction
between apposing ECs (paracellular route) without dis-
rupting the endothelial monolayer in a complex process
known as trans-endothelial migration (TEM) or diapedesis
involving the junctional adhesion molecules [8]. Alterna-
tively, leukocytes can migrate across the EC body into the
tissue known as the transcellular route [9]. Once across the
endothelial barrier, migrating lymphocytes continue to
move through the subendothelial matrix [8] and the
extravascular tissue to the site of inflammation in response
to chemotactic gradients [3]. Further details on the
extravasation process can be found in a recent review by
Nourshargh and colleagues [10].
A wide range of adhesion molecules and chemokines
expressed on the ECs are required to bind to their counter
receptors on the migrating lymphocytes, directing lym-
phocyte entry into the tissue [11]. The endothelium of
different organs is characterized by preferential expression
of combinations of these molecules, thus being endowed
with the ability to selectively recruit distinct lymphocyte
subsets. During priming, the local microenvironment and
cellular interactions induce T lymphocytes to express a
unique set of adhesion molecules and chemokine receptors
(the ‘homing’ receptors) so that antigen-experienced T
cells acquire the ability to interact with organ-specific ECs
and migrate to distinct target tissues [12–15]. Given that
recurrent infections are likely to affect the same organ, the
acquisition of tissue tropism by memory T cells contributes
to the effectiveness of recall responses. We here review the
molecular interactions and mechanisms which underlie the
ability of distinct memory T cell populations to migrate to
different non-lymphoid sites where antigen is located.
Naı¨ve T cell homing to secondary lymphoid organs
(SLOs)
Naı¨ve and memory T cells display different surface
molecules which define their functional properties and
migratory patterns [16–19]. Naı¨ve T cells have little or no
ability to produce cytokines [20]. They recirculate from the
blood, through secondary lymphoid organs (SLOs), into the
lymphatic vessels and back to the blood [14, 21]. SLOs
include peripheral lymph nodes (PLNs), spleen, gut-asso-
ciated lymphoid tissue (GALT) including Peyer’s patches
(PPs), and bronchus-associated lymphoid tissue [22].
Homing of naı¨ve T cells to the PLNs requires the
expression of CD62L and the chemokine receptor CCR7.
CD62L binds to peripheral lymph node addressin (PNAd)
expressed on the high endothelial venules (HEVs) of PLNs
and mesenteric lymph nodes (MLNs) [23], while the
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chemokine receptor CCR7 binds to the chemokines CCL19
and CCL21 expressed by HEVs of the PLNs [24, 25].
CCL21 is also expressed in PPs [26]. Naı¨ve T cells have
also been shown to utilize CXCR4, which is the receptor
for the chemokine stromal cell-derived factor 1 (SDF-1,
CXCL12), to circulate through SLOs [27]. It has been
shown that mineralocorticoid receptor signalling con-
tributes to human naı¨ve T cells migration to lymph nodes
(LNs) by increasing CD62L, CCR7, and CXCR4 expres-
sion. Sleep-dependent release of endogenous aldosterone
activates mineralocorticoid receptors on naı¨ve T cells. This
leads to an increase in the expression of CCR7 and CD62L,
as well as of CXCR4. Central memory T cells with lymph
node-homing capacity were also affected. This could
explain the beneficial effect of sleep on mounting an
adaptive immune response [28]. Naive T cells enter the
LNs via HEVs, which are specialized postcapillary venules
characterized by plump, cuboidal shapes and exclusively
found in the SLOs [29, 30]. A recent study suggested that
DCs sustain the entry of naive lymphocytes to LNs by
modulating the phenotype of HEVs during homeostasis in
adult mice. The effect of DCs on HEV is direct and
requires lymphotoxin-b-receptor-dependent signalling. In
the absence of DCs, HEV-mediated lymphocyte recruit-
ment to LNs is inhibited [31].
CCR7 is also used by DCs to traffic from interstitial
tissues into lymphatics and draining lymph nodes, in
response to the chemokines CCL19 and CCL21. Kiermaier
and colleagues showed that sialic acids on the surface of
CCR7 recognize CCL21, regulating DCs trafficking to
LNs. DCs deficient in polysialyltransferase ST8Sia IV,
responsible for posttranslational addition of sialic acids to
N- and/or O-linked glycans, fail to migrate in response to
CCL21; however, their migration to CCL19 remains
unchanged. Structure–function analysis also revealed that
CCL21 exists in an auto-inhibited conformation, which is
released upon interaction with polysialic acid addition to
CCR7, allowing DCs sufficient in ST8Sia IV to respond to
CCL21. DCs trafficking is abrogated in polysialyltrans-
ferase-deficient mice, manifesting as disturbed lymph node
homeostasis and unresponsiveness to inflammatory stimuli
[32].
Although previously thought not to require specific
mechanisms for T cell recruitment, migration of naive T
cells to the spleen has been recently shown to be facil-
itated by the angiotensin II (Ang II)/AT1 axis. Naı¨ve T
cells migrate to Ang II via the AT1 receptor. Impor-
tantly, a gradient of Ang II from peripheral blood to the
spleen was measured. Higher levels of Ang II in the
spleen induced upregulation of CD62L and CCR9
expression on T cells and production of CCL19 and
CCL25 in the spleen, thus indirectly inducing their
recruitment [33].
In humans, the majority of T cells entering the PPs are
found to be naı¨ve T cells. This process requires the inter-
action of integrin a4b7 on T cells and MAdCAM-1 on the
mucosal vasculature [26, 34]. Consistent with this obser-
vation, human naı¨ve T cells constitutively express low levels
of a4b7 [35, 36]. Other studies subsequently showed that
both CD62L and a4b7 are required in a sequential and syn-
ergistic manner to mediate naı¨ve T cell migration to the
MLNs [37]. CD62L binds to the PNAd expressed on the
MLNs, which induces the initial rolling and tethering of T
cells during transendothelial migration; a4b7 integrins sub-
sequently bind to MAdCAM-1 and mediate firm adhesion
and transmigration. T cell migration to the PPs is reduced by
55 % in mice that are deficient for CD62L; and mice lacking
b7 integrin expression have been found to display a 90 %
reduction in lymphocyte migration to the PPs [37]. Collec-
tively, this evidence highlights the importance of both
CD62L and a4b7 in naı¨ve T cell homing to the GALT.
A number of studies have revealed marked differences in
dwelling times of CD4? and CD8? naı¨ve T cells in LNs
before egressing into lymph. CD4?T cells home to LNsmore
efficiently, traverseLNs twice as quickly. In contrast, CD8?T
cells enter and leave the LNs more slowly. Cell–cell contacts
have been suggested to determine how long CD4? and CD8?
T cell spend in LNs, specifically those made with DCs via
major histocompatibility complex (MHC) molecules [38].
Expression of CCR7 and sphingosine-1-phosphate receptor 1
(S1PR1) has been shown to affect the time spent by T cells
within LNs. CCR7 promotes retention, whereas S1PR1
expression is essential to overcome this retention signal and
promote egress into the efferent lymph by interaction with its
ligand sphingosine-1-phosphate (S1P) from the circulation
[39–42]. CD69 is another major regulator of lymphocyte
migration. CD69 directly binds S1PR1 receptor on the lym-
phocyte surface and mediates internalization of S1PR1, thus
preventing lymphocyte egress [40, 41].
Memory T cell homing to non-lymphoid tissue
Naı¨ve T cells sequestered in the SLOs interact with anti-
gens presented by DCs [43], and undergo clonal expansion
and differentiation into heterogeneous antigen experienced
T cells. Recently activated T cells leave the SLOs via the
efferent lymphatics, enter the blood circulation through the
thoracic duct and travel to the inflamed tissues. Promotion
of lymphocyte egress into lymph and blood is sustained by
distinct sources of S1P [44]. Tregs have been shown to
regulate effector T cells (TEFF) migration to nonlymphoid
tissue by downregulating the expression of the S1PR1 [45].
S1PR1 has also been shown to inhibit the generation of
Tregs while driving T helper 1 (Th1) development via
signalling through the kinase mammalian target of
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rapamycin (mTOR) and antagonizing the function of
transforming growth factor-b (TGF-b) [46].
Primed T cells are a heterogeneous population consisting
of short-lived TEFF, long-lived central memory T cells
(TCM), long-lived effector memory T cells (TEM), and long-
lived tissue resident memory T cells (TRM). These cells are
defined by their different phenotypes, functions and
migratory patterns [47, 48]. Short-lived TEFF represent the
majority of recently activated T cells, and are eliminated at
the end of primary immune responses [19, 49, 50]. TCM are
able to proliferate rapidly during secondary immune
responses [51]. TCM express CD62L and CCR7, and share
migratory patterns with naive T cells; however, unlike naı¨ve
T cells they also express inflammatory chemokine receptors
which enable them to enter sites of chronic inflammation
[11]. For example, TCM preferentially accumulate and
undergo homeostatic proliferation in the bone marrow [52,
53]. CXCR4 binding to SDF-1 play an essential role in TCM
homing to the bone marrow [54]. CXCR4-deficient TCM
exhibit defective homeostatic self-renewal, which corre-
lates with impaired homing to the bone marrow. Upon re-
challenge, however, CXCR4-deficient TCM can proliferate
and differentiate efficiently while self-renewing [55]. In
contrast, both long-lived TEM and short-lived TEFF lack the
expression of CD62L and CCR7. They use instead tissue-
specific integrin and chemokine receptors to preferentially
migrate to non-lymphoid tissues [48, 56].
Primed T cells have different degree of access to distinct
tissues at steady state. Based on T cell recirculation, tissues
of the body can be characterized into three classes. First,
‘permissive tissues’, such as lung parenchyma, liver, kid-
ney, spleen and adipose tissue, are readily accessible by
TEFF without the need for any local inflammation or anti-
gen [57, 58]. Second, ‘restrictive tissues’, includes skin
epidermis, lung airways, vaginal epithelial layer, and sali-
vary glands, are inaccessible by TEFF at steady state. These
tissues require local inflammation leading to production of
inflammatory cytokines and chemokines to render ECs
permissive to TEFF migration [59–61]. Third, ‘effector
permissive tissues’, including the gut, brain, and peritoneal
cavity, are accessible by TEFF during the effector phase
when homing receptors are broadly expressed, but not by
TEM and TCM [57, 62, 63].
Upon reaching the site of infection, memory T cells
mount immune response, leading to pathogen clearance. Th
cells regulate diverse and appropriate cellular and humoral
responses to a wide range of pathogens/antigens by dif-
ferentiating into a variety of subsets—Th1, Th2, Th9, Th17
and inducible Tregs (iTregs)—defined by their distinct
profile of transcription factor, cytokine, function and
homing receptors expression. There are various mecha-
nisms to ensure the stability of different T cell subsets,
such as expression of genes turned on by transcription
factors, repression of genes conferring alternative fates,
epigenetic modifications and microRNA expression.
However, there are many examples of flexible expression
of cytokines, transcription factors and homing receptors by
established Th cells [64–66]. For example, Th17 cells can
simultaneously produce IL-17 and IFN- c [67], or IL-17
and IL-4 [68].
Migration of Th cells to peripheral sites of inflammation
is essential for execution of their effector function. Dif-
ferent Th cell subsets may use different adhesion molecules
and chemokine receptors to traffic during inflammation. It
has been reported that binding of T cell immunoglobulin
and mucin domain 1 (TIM-1) to P-selectin mediates teth-
ering and rolling of Th1 and Th17, but not Th2 and Tregs
[69]. The chemokine receptors CXCR3, CXCR6 and CCR5
are preferentially expressed on Th1 cells [70, 71], whereas
CCR3, CCR4 and CCR8, along with the prostaglandin D2
receptor CRTH2 (chemoattractant receptor homologous
molecule on Th2 cells), are expressed on Th2 cells [71–
73]. More recently, CCR6 and CCR4 have been shown to
characterize the Th17 subset, although there is also evi-
dence that Th17 cells may express CCR2 and CCR9 [74–
77]. In addition, the same Th cell lineage may use different
receptors to migrate to inflammation sites depending on
disease models. For example, Th9 cells express functional
chemokine receptors CCR3, CCR6, and CXCR3 for the
recruitment to disparate inflammatory sites; however,
during allergic inflammation, Th9 cells preferentially use
CCR3 and CCR6, not CXCR3; finally, Th9 homing to the
central nervous system (CNS) during experimental
autoimmune encephalomyelitis (EAE) involves CXCR3
and CCR6 but not CCR3 [78].
At the end of immune reaction, the tissue microenvi-
ronment provides instructive signals for some TEFF to
express molecules that enable long-term residency and
survival to become TRM. TRM does not readily circulate
and comprises a major component of lymphocyte popula-
tions in diverse peripheral tissue sites, including mucosal
tissues, barrier surfaces, and other lymphoid and non-
lymphoid sites in humans and mice [79–84]. Functionally,
TRM provide an immediate in situ immune response to
infection due to their localization in barrier tissues, and
also contain relatively high frequencies of T cell clones
specific for pathogens as TRM are likely derived from
clonally expanded TEFF responding to an infection [85–87].
Phenotypically, TRM are distinguished from circulating
TEM based on upregulated expression of CD69 by both
CD4 and CD8 TRM, and CD103 by CD8 TRM [83, 84].
E-cadherin, the ligand for CD103, is expressed on epithe-
lial cells. It is possible that interactions between E-cadherin
and CD103 contribute to maintaining TRM in peripheral
tissues. TGF-b, a cytokine secreted by various skin and
mucosal epithelial cells [88, 89], stimulates CD8 T cells to
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express the integrin CD103 [90]. Antigen-stimulated CD69
expression by TRM inhibit the egress receptor S1PR1 by
binding to the transmembrane region of S1PR1 and pro-
motes its degradation [91]. S1PR1 responds to
concentrations of S1P, which is scarce in the tissue but
highly abundant in blood and lymph [42]. S1PR1 expres-
sion requires transcription factor Kru¨ppel-like factor 2
(KLF2), which is downregulated once TEM seed the
peripheral tissue [92]. Downregulation of KLF2 also
decreases the expression of CCR7, which is another egress
receptor on tissue lymphocytes required for their migration
into the draining LNs [93, 94].
TRM have been reported to survive in memory lym-
phocyte clusters (MLCs), which are formed within the
parenchyma of the tissue after a local infection or immu-
nization. MLCs contain CD4 TRM and CD8 TRM as well as
antigen presenting cells (APCs) that hold the cluster
together [95]. MLCs appear to contain a depot of low
levels of antigenic peptides that provide antigenic stimuli
for TRM retention [63, 96]. How TRM are released from
MLCs to migrate toward the infected cells remains to be
determined.
Like other memory T cells, TRM survival depends on the
delivery of signals such as those mediated by IL-15 [93].
Recently Adachi and colleagues demonstrated that the
epidermotropism of TRM is supported by the hair follicle-
derived cytokines IL-15 and IL-7. They showed that skin
CD4 and CD8 TRM reside predominantly within the hair
follicle epithelium of the unperturbed epidermis. Hair fol-
licle expression of IL-15 was required for CD8 TRM cells,
and IL-7 for both CD8 and CD4 TRM to exert epider-
motropism. A lack hair follicle-derived cytokines led to the
failure of both CD4 and CD8 TRM to persist in the skin,
leading to impaired hapten-induced contact hypersensitiv-
ity responses [97]. A recent study by Mackay and
colleagues demonstrated that the T-box transcription fac-
tors (TFs) Eomes and T-bet combine to control the
expression of TGF-b and IL-15, which are pivotal for
CD8?CD103? TRM development and survival. They
showed that extinguishment of Eomes was necessary for
CD8?CD103? TRM development, and residual T-bet
expression maintained cell surface IL-15 receptor b-chain
(CD122) expression necessary for IL-15-induced survival
signals [98].
Another study by Hondowicz and colleagues revealed
that interleukin-2 (IL-2) signaling was required for the
formation of lung-resident memory Th2 cells, drivers of
lung allergic responses. They found that significantly
greater numbers of CD25-sufficient than CD25-deficient
allergen-specific Th2 cells were found in the lungs after
intranasal administration of allergen. They further showed
that IL-2 regulates a broad migrational program of lym-
phocyte retention and migration, regulating the early
residency of allergen-specific CD4? T cells in the lung
[99].
Memory T cells can also leave parenchymal tissue and
return to the circulation. The mechanisms leading to the
release of memory T cells from parenchymal tissue into the
circulation have been only partially characterised. The
chemokine receptor CCR7 has been proposed to guide T
cell exit from peripheral tissues and entry into afferent
lymphatics [100]. However, a conflicting report suggests
that CCR7 plays a discernible role in the trafficking of
memory CD4? T cells to the LN, either directly from the
blood or from peripheral tissues such a skin [62]. A study
has reported that murine TEM and TEFF can also be
recruited to the reactive LNs in a CCR7-independent
pathway via the chemokine receptor CXCR3 to kill anti-
gen-presenting DCs thus preventing excessive T cell
stimulation [101]. CXCR3 is upregulated on both Th1 and
CD8? T cells upon activation and maintained on these T
cell subsets throughout the effector and memory phase
[102].
After exit from the tissue, memory T cells may con-
tinue recirculating in the blood or localize in ‘reservoir’
niches: memory T cells tend to preferentially reside in
the spleen in chronic inflammation with antigen persis-
tence; alternatively they localize to the bone marrow if
the infectious/inflammatory process is acute but transient
[48, 103, 104].
Memory T cell homing to the skin
Effector/memory T cells trafficking to skin depends on the
expression of cutaneous lymphocyte-associated antigen
(CLA), CCR4 and CCR10 [105]. It has been demonstrated
that human memory T cells require the expression of CLA
to traffic to the skin by binding to E-selectin, which is
constitutively expressed at a low level by ECs in the skin
and is upregulated upon cutaneous inflammation [106,
107]. Human skin-infiltrating lymphocytes also express
CCR4, the chemokine receptor for CCL17 (also known as
the thymus and activation-regulated chemokine, TARC)
displayed on the skin post-capillary venules [108]. CCL17
is produced by dendritic cells (DC), endothelial cells,
keratinocytes and fibroblasts [109]. Further studies
revealed that CCL27 (the cutaneous T cell-attracting che-
mokine, CTACK), expressed by skin keratinocytes, also
contributes to memory T cells recruitment to the skin by
binding to its receptor CCR10 [110]. Other key molecules
participating in memory T cell homing to the skin include
the integrin a4b1 (VLA-4), which binds to VCAM-1
expressed by the endothelium [36]. T cells expressing high
levels of a4b1 preferentially home to the systemic non-
mucosal sites including the skin, CNS and bone marrow
[111].
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The requirement and redundancy of individual chemo-
kine receptors in T cell homing to the skin is still
controversial. Marked reduction of dinitrofluorobenzene-
induced allergic contact dermatitis (ACD) was observed
following neutralization of CCL27–CCR10 interactions in
Balb/c mice [112] and in CCL17-deficient mice [113].
However, Reiss and colleagues reported that simultaneous
inhibition of CCR4 and CCR10 was required to block
lymphocyte recruitment to reduce dinitrofluorobenzene-
induced ACD [108]. Similarly, Mirshahpanah et al.
demonstrated that only combination therapy of neutralizing
antibodies to CCL17, CCL27 and CCL22 resulted in
oedema inhibition using three different ACD models [114].
Differences in the relative contribution requirements for
individual chemokine receptors in T cell homing to the skin
may be in part explained by different genetic background
and experimental models used in these studies.
The skin tissue microenvironment provides instructive
signals for some recruited effector/memory T cells to
express molecules that enable long-term residency and
survival to become skin TRM. It has recently emerged that
skin TRM are crucial for protection not only against the
antigenic pathogen but also against antigenically unrelated
viruses and bacteria. Activated skin TRM can profoundly
alter the local tissue environment by inducing a number of
broadly active antiviral and antibacterial genes [115]. The
mouse skin has been shown to harbour the so-called den-
dritic epidermal T cells (DETCs), a unique, highly
specialized lymphocyte subset characterized by its den-
dritic shape [116–118]. DETCs participate in various
activities including wound healing and epidermal barrier
function [117–119]. Embryonic trafficking of DETCs to
the epidermal skin requires G protein-coupled receptor 15
(GPR15) [120]. DETCs in GPR15-/- mice remain low at
birth, but later participation of vascular E-selectin, CCR4
[105] and CCR10 [121] allows DETCs to reach near nor-
mal levels in adult skin.
Memory T cell homing to the intestine
Effector and memory T cells require the interaction of
integrin a4b7 and MAdCAM-1 to migrate to the effector
site of the gut mucosa—the lamina propria (LP) [34, 122].
MAdCAM-1 is constitutively expressed on the postcapil-
lary venules of intestinal LP and MLNs, the HEVs of the
PPs [12] and the endothelial venules of both small intestine
and colon [123]. The ability of a4b7 expressing cells to
bind to MAdCAM-1 is influenced by the level of a4b7
expression and its functional state [35]. Human peripheral
blood CD4?, CD8? T cells have heterogeneous expression
of a4b7 [35, 124]. The level of a4b7 expression is much
higher on memory cells than naı¨ve cells [35, 36]. Other
than its crucial function in mediating lymphocyte homing
to the gut, studies in mice have also revealed that a4b7
plays a critical role in the formation of GALT [125]. Mice
lacking MAdCAM-1 have a disordered architecture in their
PPs and MLNs [126]. a4b7-dependent gut trafficking is
essential but not sufficient to induce intestinal inflamma-
tion. Studies demonstrated that differential ability for a4b7
?
T cells to become colitogenic may be linked to their anti-
gen reactivity, and the reactivity was enhanced by the
presence of cd T cells [127].
In addition to its role in adaptive immunity, a4b7 is also
required for innate immune cells to migrate to intestine.
Villablanca et al. showed that b7 integrins are required for
bone marrow progenitors to reconstitute the small intestine
mononuclear phagocyte compartment including retinoic
acid (RA)-producing DCs in mLNs. Lack of b7 integrins in
the innate immune compartment markedly accelerated T
cell-mediated colitis due to decreased ability to induce
Tregs and IL-10-producing T cells [128].
Interestingly, interaction of a4b7 with MAdCAM-1 has
been proposed to contribute to immune tolerance in other
organs by selective sequestration of pro-inflammatory T
cells in the intestine. Berer and colleagues found that the
pro-inflammatory, myelin-reactive Th17 cells were enri-
ched in the intestine of EAE-susceptible mice, but failed to
reach the peripheral immune organs, resulting in the
absence of spontaneous EAE. The release of intestine-se-
questered Th17 cells via blocking of a4b7-mediated
adhesion to the intestine by treating mice with a4b7-
specific monoclonal antibodies worsened EAE [129].
Similarly, treatment of EAE mice with IL-4 increased
retinaldehyde dehydrogenase (RALDH) activity in DCs,
which enhanced RA production, induced expression of
a4b7 and CCR9 on CD4
? T cells and deviated their
migration from the dLNs-CNS route to the mLNs-gut thus
improving EAE outcome without overt colitis [130].
Upon arrival in the intestinal LP, some T cells further
migrate to the gut epithelium to become intraepithelial
lymphocytes (IELs) in a process dependent on the inter-
action of chemokine receptor CCR9 and its ligand CCL25
[131–133]. In mice, the CCR9–CCL25 axis has been
shown to play a key role in the homing of antigen-specific
CD8? T lymphocytes to the small intestine LP [134], but
less so for CD4? effector T cells [135]. CCR9 is expressed
by thymic T cells, a4b7
? LP T cells and IELs in the small
intestine in humans and mice [132, 133, 136]. CCL25 is
expressed in the thymus and the small intestinal glands and
crypts [137]. CCL25 has also been found to be expressed
by gut endothelium and epithelial cells in mice [138].
Within the murine small intestine, CCL25 is found at a
higher concentration at the proximal segments compared to
the distal segments [138]. In humans, CCL25 is abundantly
expressed in various regions of the small intestine (jejunum
and the ileum), but not in the colon or the caecum [132,
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139]. In line with these observations, CCR9–CCL25
interactions are required for memory T cell homing to the
small intestine, while they do not appear to be essential for
T cell migration to the colon in humans or mice [132, 140].
Blockade of CCL25 had no effect on murine T cell adhe-
sion in the colon in both non-inflamed and inflamed
conditions, while it significantly inhibited T cell adhesion
in the small intestine [137, 141]. Consistent with these
findings, over 90 % of both CD4? and CD8? T cells iso-
lated from the human small intestine express CCR9, in
contrast only 25 % of colonic CD4? and CD8? T cells are
CCR9 positive [132, 139]. Only a small percentage of total
circulating CD4? and CD8? T cells co-express a4b7 and
CCR9 in human peripheral blood, further enforcing the
concept that T cell homing to the small and large intestine
may not be achieved via the same pathways [133]. Instead,
CCL25 may be responsible for compartmentalizing the
mucosal immune responses within the gut [132, 136].
Optimal expression of a4b7 and CCR9, particularly by
CD4? T cells, has been found to be regulated by basic
leucine zipper transcription factor (BATF), an AP-1 protein
family factor. Wand and colleagues showed that BATF is
required for CD4? T cells to up-regulate the gut-homing
receptors in response to RA upon antigen priming and
migrate into and populate the intestine. BATF deficient
CD4? T cells failed to up-regulate the expression of CCR9
and a4b7 to wild type levels in response to RA, and are
ineffective in migration into the intestine [142].
The concept that immune surveillance of the intestine is
dependent on a large cohort of recirculating a4b7
high
memory T cells has recently been challenged by a seminal
study showing that the expression of a4b7 is lost by the
majority of circulating memory T cells—including those
activated in the GALT—despite the maintenance of pro-
tective immunity [62]. In addition, loss of a4b7 and CCR9-
mediated interactions by genetic deletion does not prevent
gut immunity from taking place [140, 143], suggesting the
existence of redundant mechanisms of T cell migration to
the intestine.
A few other molecules also play a non-redundant role in
intestinal homeostasis. Soluble lymphotoxin a produced by
RORct? innate lymphoid cells induce GALT development.
Mice deficient in soluble lymphotoxin a lacked GALT
such as PPs, abrogated IgA production in the gut and
altered microbiota composition via regulation of T cell
homing to the gut [144] as T cell-dependent regulation of
IgA production takes place mainly in PPs and requires the
formation of germinal centres and the interaction of B cells
with follicular Th cells [145]. Additionally, GPR18 has
been shown to promote the maintenance of small intestinal
IELs. Mice lacking this orphan receptor have reduced
numbers of the CD8aa, CD8ab, and cdT IELs [146].
GPR15 was also involved in the homing of T cells,
particularly Forkhead Box P3 (FoxP3)? Tregs, to the large
intestine LP. GPR15-deficient mice were prone to develop
more severe large intestine inflammation. Unlike a4b7 and
CCR9, GPR15 expression was not modulated by RA, but
by gut microbiota and TGF-b–1 [147].
Memory T cell homing to other mucosal sites
Unlike well-defined T cell homing to the gut, the molecular
pathways regulating the migration of T cells to other
mucosal sites are not fully defined. A few molecular
mechanisms have been suggested to contribute to T cells
homing to the airway. Danilova and colleagues suggested
that CCR3 is involved in the steady-state trafficking of
CD4? T cells to the human upper airway mucosa [148], as
CCR3 ligand CCL28 is preferentially expressed in various
mucosal tissues of the upper aerodigestive tract [149, 150].
Another study proposed that CCR4 contributes to T cell
lung homing imprinting. It was found that lung DCs induce
the expression of CCR4 on T cells. Lung DCs-activated T
cells traffic more efficiently into the lung and protect
against influenza more effectively compared with T cells
activated by DCs from other tissues [151]. Lim and col-
leagues suggested that CXCR4 plays a role in CD8? T cell
migration to airway tissues. They demonstrated that early
recruited neutrophils into influenza-infected trachea
deposit long-lasting SDF-1-containing trails, which provide
both chemotactic and haptotactic cues for efficient CXCR4
expressing CD8? T cell migration and effector functions in
influenza-infected tissues [152].
Molecular mechanisms regulating the migration of T
cells to the female genital tract have also been studied.
Shannon and colleagues showed that asymptomatic herpes
simplex virus (HSV)-2 infection was associated with sys-
temic T cell immune activation and a dramatic increase in
their expression of the mucosal homing a4b7 and CCR5,
which directly correlated with the number of activated and
CCR5-expressing human immunodeficiency virus (HIV)-
susceptible CD4? T cell subsets in the cervix [153]. This
may explain why asymptomatic HSV-2 infection is asso-
ciated with a threefold increase in HIV acquisition risk
[154]. In contrast, another study showed that integrin a4b1,
but not a4b7, contributes to CD4
? T cell trafficking to the
uterus. It was demonstrated that C. trachomatis infection of
the upper genital tract results in recruitment of chlamydia-
specific CD4? T cells robustly expressing the integrin
a4b1. Blocking or deleting a4b1, but not a4b7, on pathogen-
specific CD4? T cells results in the impairment of traf-
ficking to the uterus and high bacterial load [155]. Unique
challenges posed by HIV or other sexually transmitted
infections such as HSV require further research on memory
lymphocytes generation against HIV or HSV with mucosal
tissue tropism to design effective T cell-based vaccines.
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Memory T cell homing to the liver and the heart
T cell homing to the liver has received much attention in
recent years, and a number of molecular mediators of T cell
localization to hepatic tissue have been identified. Studies
in experimental models of liver inflammation have indi-
cated that Th1 cells may use VLA-4 to traffic to liver,
whilst Th2 cells may use a presently uncharacterized ligand
for endothelial vascular adhesion protein-1 (VAP-1), which
is constitutively expressed on hepatic venules and liver
sinusoids [156]. Other reports suggested the involvement
of the hyaluronan receptor CD44 in lymphocyte homing to
liver [157]. CCR5 has also been suggested as a mediator of
recruitment of T cells in the liver during acute inflamma-
tion as well as during numerous autoimmune diseases,
including multiple sclerosis, rheumatoid arthritis and type 1
diabetes [158]. First, CCR5 is preferentially expressed on
Th1 cells, and Th1 cell-mediated immune responses play a
critical role in hepatocyte damage induced by autoimmu-
nity and viral infections [159, 160]. Second, it was found
that some CCR5 antagonists might induce profound hep-
atotoxicity during clinical trials [158]. Third, CCR5
blockade/deficiency is associated with significant increase
in tissue levels of the CCR5 ligand CCL5 [161, 162],
which can promote enhanced influx of leukocytes (in-
cluding T cells) by binding to its alternative receptor,
CCR1, expressed on circulating leukocytes [161, 163].
Besides homing to the skin and liver, it has been chal-
lenging to identify unique tissue-homing signatures to
other solid organs including the heart. It has been shown
previously that the chemokine receptors CCR4 [164] and
CXCR3 [165] are contributing to T cell accumulation
during heart transplant rejection. Recently we have
uncovered a molecular mechanism of induction of T cell
cardiotropism. We found that engagement of the hepato-
cyte growth factor (HGF) receptor c-Met by heart-
produced HGF during priming in the LNs instructs T cell
cardiotropism, which was associated with a specialized
homing ‘‘signature’’ (c-Met?CCR4?CXCR3?). HGF is
expressed by healthy heart tissue and transported to local
draining LNs. Inside heart draining LNs, HGF bind to
c-Met on naive T cells, inducing higher expression of
c-Met itself and of the chemokine receptors CCR4 and
CXCR3. C-Met triggering was sufficient to support
cardiotropic T cell recirculation, while CCR4 and
CXCR3 sustained recruitment during heart inflamma-
tion. In steady state conditions, engagement of cMet
induces autocrine release of beta chemokines, which
favour T cell recruitment via their receptor CCR5. Under
inflammatory conditions, cardiac tissue releases higher
levels of the HGF and chemokines CXCL10 and CCL4,
which facilitate HGF-primed T cells recruitment to the
heart [166].
Mechanisms of homing receptor acquisition
The ability of local microenvironment to imprint T lym-
phocytes with a specific set of homing receptors has long
been recognized. Tissue-associated DCs appear to be
capable of imprinting the tropism of a T cell during the
priming phase. It was first demonstrated in mice that only
DCs isolated from the MLNs and PPs preferentially up-
regulated gut-homing receptors a4b7 and CCR9 expression
when activating naı¨ve T cells [134, 167, 168]. In contrast,
T cells activated in the cutaneous secondary lymphoid
tissue expressed skin-homing receptors such as P-selectin
glycoprotein ligand-1 (PSGL-1; CD162) [168, 169]. The
mutually exclusive sets of skin and gut-homing receptors
expressed by T cells commit them to either destination [36,
133].
More recent studies have shed light on the molecular
mechanisms of ‘local’ imprinting. While tissue-associated
DCs appear to be capable of imprinting the tropism of a T
cell during the priming phase, additional signals within the
tissue microenvironment may be required to imprint and
maintain a particular homing program. A study by Iwata
and colleagues highlighted the key role of the vitamin A
(VA) metabolite RA in the imprinting of gut homing
specificity on T cells [170]. VA enters the body exclusively
through diet [171], absorbed and processed primarily in the
small intestine [172]. VA is inactive and requires enzy-
matic processing to become activated [173]. It is first
converted to retinal catalysed by ubiquitous alcohol dehy-
drogenases (ADH), and then to RA catalysed by cell
specific RALDH [170, 174–176]. DCs in GALT express
RALDH, which metabolise VA to RA [170, 171]. RA
along with antigens is presented by DCs to naı¨ve T cells
during priming. RA binds to its receptors—RAR and RXR
expressed on naı¨ve T cells, which then up-regulate the
expression of a4b7 and CCR9 [170, 171, 177–180].
CD103? DCs express higher levels of enzymes required
for VA metabolism compared to CD103- DCs, represent
the major migratory DC population in the intestinal LP and
are believed to be most effective at generating a4b7
?
CCR9? CD8? T cells compared to DCs from MLNs or PPs
[181]. However, The MLNs are believed to serve as the
primary site where imprinting of gut homing specificity
occurs as antigen-loaded DCs are carried into the MLNs
via draining lymphatics [182–186].
DCs can also internalize exogenous RA produced by
other cells in the gut such as LP macrophages [176], MLN
stromal cells [187] and gut epithelial cells [188]. However,
the contribution of RA from sources other than DCs
towards the imprinting process is not fully established
[189]. RA can also be produced by other DC populations,
particularly in DCs located at the environmental interfaces,
such as the skin, the lungs, and the corresponding draining
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LNs [190, 191]. Compared to DCs from GALT, DCs from
the environmental interfaces are shown to be less effective
at converting VA to RA, and are therefore less effective at
inducing a4b7 and CCR9 expression on T cells [170].
In addition to the role of producing and presenting RA to T
cells, DCs also express the RA receptors and are able to
respond directly to RA [192]. RA can modulate monocyte-
derived DCs towards a mucosal-type DCs, which produce IL-
6 and TGF-b and has capacity to induce gut-homing receptors
on T cells [193]. RA can also influence the migratory prop-
erties of DCs. RA induces expression of the matrix
metalloproteinases (MMP)-9 andMMP-14 [194, 195].MMP-
9 and MMP-14 are involved in DC migration [196, 197]. RA
promotes the migration of DCs in vivo toward draining LNs
in a murine model of cancer [194]. Similar mechanisms
involving VA metabolism are also used to instruct Tregs and
B cells to become gut-tropic [180, 198–200].
Apart from inducing a gut-homing phenotype, RA also
prevents the upregulation of skin-homing receptors by T
cells [170]. It has been suggested that the acquisition of a
skin-homing phenotype might be the default pathway for T
cell activation in the absence of RA or when RAR sig-
nalling is blocked [201]. For example, a distinct
inflammatory Th2 with homing receptors for skin and
inflammatory sites was induced by DCs from MLNs in
VA-deficient mice. The MLN-DC subset from VA-suffi-
cient mice induced a similar T cell subset with homing
receptors for skin and inflammatory sites in the presence of
RAR antagonists. RA inhibited this induction [202].
Like the role of VA in the gut-homing imprinting,
vitamin D3 has been implicated in the induction of a skin-
homing phenotype in T cells. Skin-resident DCs have been
shown to process vitamin D3, the inactive pro-hormone
naturally generated in the skin by exposure to the sun, to
1,25(OH)(2)D(3), the active form of vitamin D3.
1,25(OH)(2)D(3) signals have been shown to induce
CCR10 expression, which promote T cell trafficking to
and/or retention in the skin epidermis via binding to its
ligand CCL27 secreted by keratinocytes [173]. In contrast,
1,25(OH)(2)D(3) suppresses the expression of the gut-
homing receptors a4b7 and CCR9. Skin stromal cell-
derived prostaglandin E2 can also decrease gut-homing
CCR9 expression upon T cell priming via inhibiting
RALDH expression in mouse and human DCs. It was
found that prostaglandin E2 stimulated the expression of
the inducible cyclic AMP early repressor, which appears to
directly inhibit RALDH expression in DCs [203].
Recent findings have provided strong evidence that
soluble factors produced in selected tissues and drained in
the local lymphatic stations contribute to the topographic
imprinting of T cells during activation. It is known that
tissue-derived small molecules can be directly delivered to
draining LNs by anatomically defined conduits [204].
Some of these molecules are produced in a tissue-specific
manner and can therefore define the topographic identity of
the tissue where they are generated and possibly contribute
to T cell homing imprinting. For example, skin-derived
soluble factors have been shown to induce the skin homing
receptor CCR8 in T cells [205]. We have reported recently
that HGF produced by the myocardium is transported to the
heart-draining LN either passively or bound to DCs [166].
Binding of HGF to its receptor c-Met on T cells induce
intracellular signalling cascade involving Akt and STAT3
engagement, leading to increased expression of CCR4 and
CXCR3 and secretion of several chemokines, including
CCL3, CCL4, CCL5, CCL17, and CCL22. This mecha-
nism represents an autocrine loop, by which T cells—once
primed by HGF—stimulate both receptors and their ligands
to re-direct T cells to heart tissue.
A summary of the homing receptors used by memory T
cells to migrate to different tissues is provided in Fig. 1.
T cell receptor: the ultimate addressin?
Primed T cells must patrol very large areas to locate
antigen-rich tissue to exert their function. Together with
the acquisition of homing receptors during activation and
differentiation, additional antigen-driven mechanisms have
been proposed to orchestrate the targeted delivery of
memory T cells to antigen-rich tissues. Several mecha-
nisms could contribute to the accumulation of antigen-
specific T cells at antigen-bearing sites: (a) a direct effect
of antigen recognition on the recruitment of T cells; (b) the
retention of antigen-specific T cells; (c) local proliferation
of antigen-specific cells.
T cell receptor (TCR) recognition of antigen/MHC
complexes presented by the endothelium has been reported
both in vitro and in vivo to contribute directly to the
recruitment of antigen-specific T cells. In vitro, cognate
recognition of B7-deficient human and murine ECs was
shown to enhance T cell trans-endothelial migration with-
out inducing unresponsiveness [206–208]. In vivo, antigen
presentation by the endothelium has also been shown to
sustain the recruitment of specific T cells to antigenic sites.
For instance, islet-specific homing by insulin-specific
CD8? T cells was abrogated in mice lacking MHC class I
(MHC I) expression, or in mice displaying impaired insulin
peptide presentation by local endothelium due to lack of
insulin secretion [209]. Similarly, up-regulation of male
antigen HY presentation by local vessels led to peritoneal
recruitment of HY specific CD8? lymphocytes T cells in
male, but not female mice [210]. Indirect evidence impli-
cating the requirement of MHC I molecule upregulation for
T cell localization to antigen-rich non-lymphoid tissue was
first provided by studies showing that homing of insulin-
specific CD8? T cells to the islets during the onset of
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autoimmune diabetes in non-obese diabetic (NOD) mice
in vivo was impaired in IFN-c-deficient NOD mice [211].
In particular, T cell diapedesis was significantly dimin-
ished. This effect was reversible by treatment of the
animals with recombinant IFN-c. MHC class II molecule
expression by microvascular endothelium in the CNS
precedes and is required for the formation of T cell infil-
trates in EAE in guinea pigs [212]. Presentation of cognate
antigen by either ECs or bone marrow-derived APCs that
extend into the capillary lumen was sufficient for T cell
migration into graft tissues [213]. Intravital microscopy
revealed that antigen presentation by the endothelium
selectively enhances T cell diapedesis into the tissue
without affecting rolling and adhesion.
TCR signals can also exert indirect effects on T cell
migration. The identification of a crosstalk between TCR-
and chemokine receptor-mediated signalling indicates that
TCR-induced signals might also affect T cell responses to
chemokines. Both TCR signalling and chemokine receptor
signalling trigger downstream integrin activation, e.g,
Lymphocyte function-associated antigen (LFA)-1 and
VLA-4 [214, 215]. Moreover, signal transduction induced
by CXCR4 in human T cells requires the zeta-associated
protein 70 (ZAP-70), a key element in TCR signalling
[216]. In addition, chemokine receptor expression is reg-
ulated by T cell activation [217]. Chemokines contribute to
antigen-specific T cells homing following cognate recog-
nition of the endothelium in vivo [209, 218].
The relative contribution of antigen-specific and non-
antigen-specific signals to memory T cell recruitment is
likely to be determined by the intensity of the inflam-
matory response. It is possible that TCR-mediated
primed T cell localization to antigenic sites may be
essential to ensure efficient, rapid memory responses in
the event of limited inflammatory signals. For example,
insulin-specific T cells are efficiently recruited to pan-
creatic islets of various mouse strains that are free of pre-
existent inflammation [209]. In contrast, severe inflam-
mation or a pre-existing large antigen-specific T cell
repertoire (for example during direct alloresponses) may
override the requirement for selective antigen-dependent
T cell recruitment [219].
Fig. 1 Memory T cell tissue homing. Memory T lymphocytes
acquire the expression of homing receptors, imprinted during priming
in the draining LNs, which enable their migration to specific tissues. T
cells trafficking to the heart occurs due to the expression of C-met
which binds to its ligand HGF released by the heart. This binding
induces the upregulation of CCR4 and CXCR3. The interaction of
a4b7 and CCR9 with their respective ligands MAdCAM-1 and
CCL25 results in gut specific homing. Migration into the skin occurs
due to the expression of CCR4, CCR10, a4b1 and CLA which
interact with their respective ligands CCL17, CCL27, VCAM-1 and
E-selectin on the endothelium. Th1 cell homing to the liver is been
reported to use VLA-4 and CCR5 whereas Th2 cells use VAP-1
which is expressed on hepatic venules and liver sinusoids. CCL3
which binds to CCR3 and CCR4 have been shown to contribute to
imprinting a lung homing signature. At the end of an immune reaction
some T lymphocytes become tissue resident following upregulation of
CD69 and CD103
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Co-stimulatory molecules regulate T cell migration
Co-stimulatory signals such as those mediated by CD28
delivered to T cells in conjunction with TCR engagement
are required to sustain T cell division, differentiation and
survival [220]. Negative co-stimulators (such as CTLA-4)
counteract these effects thus promoting homeostatic
mechanisms and preventing autoimmunity. These co-
stimulators have also been shown to regulate adhesion
molecules activity and cytoskeletal rearrangement in vitro
[221–223]. In vivo, CD28-mediated signals are required for
primed T cells to leave lymphoid tissue following priming
and promote the localization of T cells to target tissue. A
prominent feature of CD28-deficient immune responses is
the inefficient localization of primed T cells to non-lym-
phoid antigenic site [224–227]. TCR-transgenic T cells
carrying a mutation in the cytoplasmic tail of CD28
(CD28Y170F) that abrogates phosphatidylinositol-30-kinase
(PI3K) recruitment without leading to defects in clonal
expansion failed to localize to target tissue following
priming [227, 228].
The mechanism by which CD28 facilitates migration of
primed T cells to non-lymphoid tissue is unclear. CD28
does not appear to directly mediate adhesion [229], but
may favour primed T cell access to non-lymphoid tissue by
inducing integrin mediated-adhesion. Additional mecha-
nisms, such as transcriptional regulation of chemokine
receptor expression by CD28, are likely to be involved
[227, 230]. Despite sharing adhesion-inducing and pro-
migratory properties in vitro [231], CTLA-4-mediated
signals lead to effects antagonistic to those induced by
CD28 on T cell migration in vivo. Tissue infiltration by
murine T cells was abrogated by CTLA-4 ligation [227].
In addition to CD28 and CTLA-4, a number of other
costimulatory molecules have been implicated in the reg-
ulation of T cell migration. For example, OX40/OX40
ligand interaction has been shown to be required for T cell
migration to germinal centres [230], and the inducible
costimulatory molecule (ICOS) regulates human memory
T cell migration through tumour necrosis factor (TNF)-a-
treated ECs [232].
Mechanisms of TCR- and costimulation-driven T
cell trafficking: the central role of PI3K signals
PI3K signaling mediates not only events downstream of
TCR and CD28 [233, 234] leading to T cell division and
differentiation, but also events leading to T cells migration.
It has been shown that both TCR- and CD28-driven T cell
migration rely upon PI3K p110d activity [227, 235–238].
Studies using T cells from mice expressing a catalytically
inactive p110d isoform or treated with selective p110d
inhibitor, revealed an essential role for this molecule in
TCR-dependent localization of both CD4? and CD8? T
cells in an antigen-specific transplantation model [235,
239]. Recent evidence also strongly correlates CD28-in-
duced migration with PI3K (likely p110d) signalling. TCR-
transgenic mice carrying an ovalbumin-specific T cell
receptor (OT-II) and a mutation in the cytoplasmic tail of
CD28 that abrogates class I PI3K recruitment without
leading to defects in clonal expansion (CD28Y170F) were
generated to allow discrimination of conventional co-
stimulation-driven clonal-expansion from their ability to
infiltrate antigenic tissue (OT-II/CD28Y170F). OT-II and
OT-II/CD28Y170F naı¨ve T cells proliferated equivalently
following immunization with antigenic peptide. Unlike
OT-II cells, However, OT-II/CD28Y170F CD8? memory T
cells failed to localize to target tissue upon antigen chal-
lenge [228].
A few mechanisms have been suggested to account for
the role of TCR- and CD28-induced PI3K signaling in
memory T cell migration into target tissue. Naı¨ve T cells
express CD62L, CCR7 and S1PR1, which facilitate
their trafficking to SLOs. Following TCR and CD28
engagement, the PI3K-Akt-mTOR axis promotes the tran-
scriptional downregulation of CD62L, CCR7 and S1PR1
via the inhibition of the transcription factor KLF2, leading
to T cells egress from draining LNs and traffic into non-
lymphoid tissues [93, 94, 240, 241]. PI3K-Akt signaling has
also been implicated in F-actin polymerization and myosin
assembly [242–245]. Accordingly, PI3K(s) contribute to
several aspects of the migratory machinery, including gra-
dient sensing, signal amplification, actin reorganization and
hence cell motility [246–248].
Activation of PI3K is also a robust signaling event
shared by most homoeostatic and inflammatory chemokine
receptors expressed on T cells [249]. There has been
interest in exploring the role of PI3K-dependent signaling
in the T cell migratory responses after chemokine stimu-
lation. Pharmacological and genetic approaches have been
employed to assess the contribution of individual class I
PI3K isoforms to the T-lymphocyte’s migratory response
to several chemokines. In contrast to TCR or CD28-in-
duced migration, PI3K inhibitors were found to have little
effect on chemokine induced T cell migration both in vitro
and in vivo. T-lymphocyte arrest and adhesion to HEVs in
exteriorized PP [250] or transendothelial migration in
laminar-flow chambers [251] in response to either CXCR4
and/or CCR7 ligation is unaffected by PI3K inhibitors.
There was no defect in the p110d mutant mice of either
normal constitutive trafficking or migratory response to
chemokines. Further studies revealed that responses to
chemokines in T cells require a largely PI3K-independent
activation of the small GTPase DOCK2, a mammalian
homolog of Caenorhabditis elegans CED-5 and Droso-
phila melanogaster Myoblast City [252].
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Regulatory T cell (Treg) trafficking
Tregs were first identified in mice by Sakaguchi and co-
workers in 1995 as a subset of CD4? T cells with a con-
stitutive expression of IL-2 receptor alpha-chain CD25
[253]. Tregs are characterized by constitutive expression of
the transcription factor FoxP3, which confers on them
potent suppressive activity [254, 255]. Tregs suppression
requires activation signals via the TCR; however, once
activated their suppressor function is antigen non-specific
[256]. Tregs exert their function by suppressing effector T
cell responses, thus preventing the development of
autoimmunity [257, 258]. Mice with a spontaneous muta-
tion in the FoxP3 gene—known as ‘scurfy’ mice—develop
fatal autoimmune diseases affecting multiple organs [254].
Similarly, humans with mutations affecting the FoxP3 gene
suffer from severe autoimmunity (IPEX: immune polyen-
docrine enteropathy X-linked syndrome) [255]. In scurfy
mice and IPEX patients, chronically activated self-reactive
CD4? T cells are found to be responsible for the devel-
opment of pathology [259].
Naturally occurring Tregs (nTregs) develop in the thy-
mus and constitute approximately 5–10 % of all peripheral
CD4? T cells in mice [260]. In mice, both CD25high and
CD25low of the CD4?CD25? population exhibit suppressor
functions. However, in humans only CD4?CD25high T cells
are suppressive [261]. Human CD4?CD25high Tregs
account for 1–2 % of the total peripheral CD4? T cell
population [261]. It must also be considered that high
levels of CD25 and FoxP3 are transiently expressed by
recently activated human T cells, which do not display
suppressor functions [262, 263]. Thus, a human Tregs-
specific marker has yet to be identified. Despite this,
markers important for the survival and the suppressive
functions of Tregs have been identified such as CTLA-4
and glucocorticoid-induced TNF-receptor-related protein
(GITR) [264, 265].
Induced Tregs (iTregs)
Aside from nTregs, Tregs can also be induced from naı¨ve
CD4? CD25- T cells both in vitro and in vivo [266–268].
Both nTregs and iTregs do not proliferate in vitro and are
able to suppress effector T cell responses both in vitro and
in vivo [269]. Thus far, the differentiation of naı¨ve T cells
into iTregs in vivo has been documented in the murine
intestine [177], inflamed lung [270], tumours [271] and
transplanted tissues [272].
The possible underlying mechanisms of iTregs genera-
tion have also been explored in both humans and mice.
In vitro generation of iTregs has been shown to be
dependent on TGF-b and IL-2 [266, 273]. The VA
metabolite RA also facilitates the generation of Tregs
mediated by TGF-b following priming by DCs in the
secondary lymphoid tissue [177, 180]. In addition, studies
have shown that CD103? DCs in the small intestinal LPs
and the MLNs are capable of generating FoxP3? Tregs in
the presence of TGF-b and RA [177, 180]. ITregs can also
be generated from CD4?CD25- T cells cultured with
rapamycin [274].
ITregs generated under different conditions may display
different migratory patterns. iTregs generated in the pres-
ence of RA also express fully functional gut-homing
receptors a4b7 and CCR9, therefore they migrate primarily
to the gut [200]. ITregs generated in the presence of
rapamycin express relatively high levels of CCR7 and
possess a relatively greater lymphoid tissue-homing
capacity [275]. Different characteristics of iTreg generated
with different methods need to be taken into consideration
when designing therapies for immune-mediated disorders.
Treg homing to SLOs
Treg-mediated immune suppression operates in both SLOs
[276] and non-lymphoid tissue [277, 278]. Appropriate
trafficking and retention mediated by distinct chemokine
and adhesion receptors are indispensable for Tregs to
efficiently modulate immune response at sites where reg-
ulation is required [279–281]. nTregs express CD62L and
CCR7, which facilitate their homing to the T cell area of
LNs [276, 282, 283]. At the T cell zone, naı¨ve Tregs may
recognize antigens and become activated [284]. Upon
activation, Tregs lose CCR7 expression and reduce CD62L
expression [285, 286] and gain the expression of CXCR5, a
chemokine receptor that promotes Treg migration into
germinal centres in response to CXCL13, where they reg-
ulate the magnitude and characteristics of antibody
responses [287, 288].
Migration to SLOs is required for Tregs to control the
induction phase of an immune response [276, 289]. It was
uncovered that CD62L? Treg homing to LNs is necessary
for the induction of transplantation tolerance [290].
CD62L? Tregs, rather than CD62L- Tregs, protect from
acute graft-versus-host disease (GVHD) [291, 292] and
efficiently delay diabetes in pre-diabetic NOD mice [293].
In contrast, Tregs from CCR7 knockout mice were ineffi-
cient in homing to LNs and did not suppress antigen-
induced activation of T cell [294].
Within SLOs, Tregs need close physical contact with
effector cells to exert their regulatory function [295]. Thus,
effective suppression can only occur when homing of Tregs
runs in parallel with that of effector T cells. Evidence
suggests that Tregs and effector T cells home to similar
areas of the LNs [289]. In a model of diabetes, in vivo two-
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photon microscopy revealed that Tregs co-localised with
diabetogenic T cells in pancreatic LNs, and inhibited their
antigen-dependent swarming and arrest [289]. Further-
more, using a recently described multiplex, quantitative
imaging termed histocytometry, Liu et al. observed that
within secondary lymphoid tissues in mice, Tregs exist in
discrete clusters with IL-2-producing CD4? T cells. Dis-
ruption of their physical co-clustering with effector T cells
by inducible ablation of TCR expression by Tregs resulted
in uncontrolled effector T cell responses [296].
Treg cell homing to non-lymphoid tissue
Tregs need to migrate from circulation to non-lymphoid
sites of inflammation to control effector immune responses
[285, 297, 298]. Similarly to conventional T cells, Tregs in
the microvasculature must undergo rolling, adhesion and
transmigration mediated by distinct chemokine and adhe-
sion receptors to arrive at the site of inflammation. Selectin
ligands play a vital role for appropriate Tregs localisation
in the periphery, particularly in the skin. In steady-state
conditions, low-frequency rolling in dermal microvessels
were P-selectin-dependent, whereas during most phases of
inflammation, P-selectin and E-selectin both contributed to
rolling [299]. Mice lacking PSGL-1, the main ligand
required for P-selectin-dependent rolling, develop a more
severe form of the EAE model of multiple sclerosis [300].
FucTVII, the enzyme responsible for generation of func-
tional selectin ligands, is required for selectin-mediated
leukocyte rolling in the microvasculature and leukocyte
entry into the skin [301, 302]. Despite having normal
in vitro regulatory capacity and populating lymphoid
organs and peripheral sites such as the lung and intestine as
efficiently as FucTVII sufficient Tregs, FucTVII deficient
Tregs were severely restricted in their homing capacity to
the skin, and unable to regulate contact hypersensitivity-
associated skin inflammation [297].
Like conventional T cells, Treg trafficking to different
tissues is determined by the combined expression of che-
mokine receptors and adhesion molecules [303]. Activated
Tregs express aEb7, which binds its ligand E-cadherin and
might predispose their retention to epithelial sites of
inflammation in the periphery [285, 304]. Conversely, the
aE
- Treg population was shown to be more efficient than aE
?
Tregs at homing to LNs [297]. It has been shown that
increased CLA or a4b7 expression by circulating human
Tregs is associated with reduced risk of skin or gut acute
GVHD, respectively [305]. Also like conventional T cells,
the migratory properties of Tregs are shaped by the tissue
microenvironment and organ-resident DCs during priming
[198]. Tregs activated in the LNs draining a tissue acquire
homing receptors that allow them to migrate back to the
inflamed tissue. For example, Tregs activated in MLNs and
PPs acquire a4b7 and CCR9, which direct their trafficking
to the gut. By contrast, Tregs activated in PLNs express
CCR8, which promote their migration to the skin [306].
Recent studies have shown that a large proportion of
circulating human Tregs express the skin-homing receptors
CLA and CCR4. In contrast, only a small number of cir-
culating Tregs express gut-homing receptors a4b7 and
CCR9 and aEb7 [307, 308]. This observation raises the
question of how Tregs execute their suppressor functions in
the gut [264]. A possible explanation is that MAdCAM-1,
expressed constitutively on the postcapillary venules of
intestine, is also capable of binding to CD62L found on
Tregs in humans and mice [15, 297, 309]. CD62L therefore
may target Tregs to the MLNs and the PPs where they
carry out suppressor functions [307].
There is also evidence to suggest that Tregs can recir-
culate between SLOs and non-lymphoid tissues. A study by
Tomura et al. showed that in steady-state Tregs constitu-
tively migrated from the skin to draining LNs in mice.
During skin inflammation, Tregs in circulation infiltrate the
periphery, traffic to dLNs, and then recirculate back to the
skin [310]. By doing so, Tregs can efficiently regulate both
the induction phase and effector phase of immune response.
Treg migration to the inflamed liver has been shown to
be supported by the common lymphatic endothelial and
vascular endothelial receptor (CLEVER-1; also known as
FEEL-1 and stabilin-1). Shetty and colleagues demon-
strated increased endothelial expression of CLEVER-1 at
sites of leukocyte recruitment to the inflamed human liver
including sinusoids, septal vessels, and lymphoid follicles
in inflammatory liver disease and tumor-associated vessels
in hepatocellular carcinoma. Together with ICAM-1 and
vascular adhesion protein-1 (VAP-1), CLEVER-1 can
support transcellular migration of Tregs. CLEVER-1
inhibition reduced Treg transendothelial migration by
40 % and when combined with blockade of ICAM-1 and
VAP-1 reduced it by[80 % [311].
The bone marrow is a critical site of immunity as studies
have shown that long-lived, antibody-secreting plasma
cells [312] and functional memory T cells [52, 53] reside in
this organ. A subset of activated Tregs up-regulates
CXCR4 expression and become responsive to SDF-1,
enabling them to migrate to the bone marrow [313], where
Tregs can suppress immune responses [53, 312, 314]. It has
been described that in bone marrow of human and mice
more than 25 % of CD4? T cells are Tregs—as compared
to 5–10 % of CD4? T cells which are Tregs in the
peripheral blood. Tregs exit from the bone marrow is
achieved through granulocyte colony-stimulating factor
(G-CSF) and reduced expression of SDF-1 [313]. Thus, it
appears that Tregs are actively, rather than passively,
recruited and retained in the bone marrow to regulate
immune responses during homeostasis.
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Long-term resident Tregs have been found in a wide
range of tissues under homeostatic conditions, such as
skin, gastrointestinal tract, lung, liver and adipose tissue
[315–318]. Expression of particular sets of chemokine
receptors not only is involved with Tregs recruitment to
specific tissue sites, but also may facilitate retention of
Tregs. Antigen recognition is also important in Treg
survival and development of tissue tropic activity [319].
We and others have demonstrated that expression of TCR
specific for an antigen expressed in a given tissue by
Tregs promotes its recruitment, retention and clonal
expansion in that location [320, 321]. nTregs predomi-
nantly recognise self-antigens [319]. We have reported
that nTreg recognition of self-antigens expressed by
endothelial cells in target tissue is instrumental for effi-
cient Treg recruitment in vivo [320]. This may explain
why recipient-derived Tregs are less efficient at modu-
lating rejection of vascularized tissue graft [322]. A recent
human study showed that Tregs comprise a high propor-
tion (30–40 %) of CD4? T cells in paediatric tissues but
are present at much lower frequencies (1–10 %) in adult
tissues. Paediatric tissue Treg cells suppress endogenous
T cell proliferation and function, avoiding excessive
activation as a result of diverse new antigens in early life
[323]. Similarly, murine study by Scharschmidt et al.
observed the accumulation of antigen-specific Tregs in
neonatal skin is required to establish tolerance to skin
commensals. Transiently blocking the migration of Tregs
into the skin with S1PR1 antagonist FTY720 between
postnatal days 5 and 11 to block the egress of lympho-
cytes from the thymus and skin dLNs [42] led to
increased skin inflammation after challenge with same
skin commensal bacteria in adult mice. This inflammation
was associated with a reduction of antigen-specific Tregs
and increased numbers of antigen-specific effector CD4?
T cells in the skin and skin dLNs [324]. The roles of
tissue homing and antigen recognition are intertwined.
Tregs utilize tissue homing molecules to migrate to the
site of cognate antigen expression and lymphoid organs
draining that site, and then receive TCR-derived signals
that are critical to its survival and proliferation [325].
The number of Tregs in tissue has been observed to
increase during inflammation. Regarding the relative con-
tributions of tissue-resident versus recently recruited Tregs
in the regulation of inflammation, it has been suggested that
tissue-resident Tregs are sufficient to restrict mild inflam-
mation stemming from recognition of commensal microbes
or self-antigen in the periphery, but upon recognition of
foreign microbial antigen, recruitment of additional Tregs is
necessary to keep inflammation under control [315].
Tregs have been used to suppress allograft rejection in
transplantation settings. T effector cells with high avidity
for donor antigens migrate to an allograft to mediate
transplant rejection [326]. Tregs must be able to migrate to
transplanted organs to effectively suppress intra-graft anti-
donor immune response. Intra-graft Tregs have been
associated with tolerance induction. Tregs with unique
chemokine profile have been shown to migrate to different
graft tissues. CCR4 expression is associated with the
recruitment of Tregs in heart allograft of tolerant mice
[278]. Chemokine receptors CCR2, CCR4, CCR5 and P-
and E-selectin ligands expression determines Tregs
migration into islet allografts. CCR5 has been shown to
play an important role in Tregs recruitment to both lym-
phoid tissues and GVHD target organs [327].
A summary of the different homing pathways used by
Treg cells is summarized in Fig. 2.
Emerging evidence suggests that Treg trafficking and
compartmentalization can be modulated allowing efficient
tissue targeting following ex vivo expansion. Siewert and
colleagues have shown that Tregs can be configured both
in vitro and in vivo with organ-selective homing properties
allowing efficient migration into target tissue. For example,
a4b7
? Tregs generated in vitro are able to effectively clear
acute inflammation in the small intestinewhen transferred into
the diseased animals [328]. This suggests that modulation of
Tregs designed to serve for therapeutic purposes with specific
homing properties is feasible for adoptive T cell therapy.
Concluding remarks
While the majority of existing vaccines rely on circulating
antibody for long-lasting protection, unique challenges
posed by HIV or other sexually transmitted infections such
as HSV require T cell-based vaccines or a combination of
both T and B cell based vaccines. Successful T cell-based
vaccination strategies depend not only on the generation of
immunological memory against pathogen, but also on
topographic memory of sites of infection as well as the
establishment of TRM. Further understanding of how T cell
tissue tropism is generated and maintained will aid in the
design of efficacious vaccines. Due to the effect of local
microenvironment on tissue homing acquisition, efforts
should be made to design a vaccine that uses local immu-
nization. Studies have shown that mucosal vaccination
induces more recruitment of antigen-specific T cells to
mucosal sites compared to distal immunization [329].
However, the recent finding that soluble factors can induce
the acquisition of T cell homing receptors to selected tissue
paves the way to the generation of combinatorial vaccines
including ‘cues’ for the design of the desired tissue tropism.
A relatively unexplored issue is the plasticity of topo-
graphic memory. Understanding the genetic and epigenetic
regulation of homing receptor expression will be crucial to
the design of vaccination schedules involving
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combinatorial formulations. If, as it has been suggested, T
cell trafficking programming is plastic, the possibility of
reprogramming T cell tissue tropism upon a second antigen
encounter provides great potential for a variety of thera-
peutic manipulations of immune responses.
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